BioCentury
ARTICLE | Clinical News

Restasis cyclosporine regulatory update

December 6, 2010 8:00 AM UTC

Allergan said Health Canada approved Restasis 0.05% cyclosporine ophthalmic emulsion to treat moderate to moderately severe dry eye disease. Restasis is already approved in the U.S. to increase tear p...